Welcome to our dedicated page for Moelis & Co SEC filings (Ticker: MC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page compiles Moelis & Company (NYSE: MC) SEC filings, giving investors structured access to the firm’s regulatory disclosures as a global independent investment bank in the investment banking and securities dealing industry. Filings such as Form 8-K, Form 10-K, Form 10-Q, and Form 4 provide insight into Moelis & Company’s financial performance, governance, and insider activity.
Moelis & Company uses Current Reports on Form 8-K to announce material events, including quarterly financial results and board changes. For example, the company files 8-Ks when it releases earnings for specific quarters and when its Board elects a new independent director, detailing items such as results of operations, updated investor presentations, and director compensation arrangements.
Investors can look to the firm’s annual reports on Form 10-K and quarterly reports on Form 10-Q (when available on this page) for more comprehensive information on revenues, expenses, net income, segment drivers, and risk factors. Moelis & Company also discusses its use of Adjusted (non-GAAP) metrics in conjunction with GAAP results, and its filings reference the ownership structure of Moelis & Company Group LP and related tax treatment.
In addition, Form 4 insider transaction reports, when present, can help users track purchases, sales, and equity awards involving Moelis & Company’s directors and executive officers. Proxy-related filings may further describe board composition, director independence, and compensation practices, as illustrated by the firm’s disclosure of compensation for an independent director in a Form 8-K.
Stock Titan enhances these filings with AI-powered summaries that highlight key points from lengthy documents, explain complex sections in simpler language, and surface notable items such as changes in revenues, margins, dividends, or governance. With real-time updates from EDGAR and organized access to 10-Ks, 10-Qs, 8-Ks, and Form 4s, this page helps users quickly understand what Moelis & Company is reporting to regulators and how those disclosures relate to its advisory-focused business model.
Moelis & Company reported an equity compensation change for its Chief Financial Officer, Christopher Callesano, in a Form 4 dated 12/04/2025. The filing shows the CFO received multiple grants of incentive restricted stock units (RSUs) as dividend equivalents on existing unvested RSUs from the company’s 2020–2024 incentive programs.
New dividend-equivalent incentive RSUs were credited on December 4, 2025, including 4.3 units tied to 2020 awards, 7.44 units tied to 2021 awards, 17.58 units tied to 2022 awards, 16.1 units tied to 2023 awards, and 16.07 units tied to 2024 awards. Following these transactions, the CFO beneficially owns 444.01, 767.8, 1,814.93, 1,662.43 and 1,658.54 derivative securities under the respective incentive RSU programs, all held directly.
Each RSU represents the right to receive either one share of Moelis Class A common stock or cash equal to its fair market value upon settlement at an exercise price of $0. The dividend-equivalent RSUs will vest at the same time as the related underlying unvested incentive RSUs from grant dates in February 2021, 2022, 2023, 2024 and 2025.
Moelis & Company reported an equity award transaction for its Chief Operating Officer, Katherine Pilcher Ciafone, on 12/04/2025. The Form 4 shows grants of incentive restricted stock units (RSUs) that were issued as dividend equivalents on her existing unvested RSUs from 2021, 2022 and 2023.
New incentive RSUs cover 14.34, 27.23 and 58.12 shares of Class A common stock, all at an exercise price of $0. Following these transactions, she beneficially owns 1,480.02, 2,811.24 and 5,999.54 derivative securities tied to Class A common stock under the respective 2020, 2021 and 2022 incentive awards. Each RSU represents the right to receive either a share of Class A common stock or cash equal to its fair market value upon settlement, and the dividend-equivalent RSUs vest at the same time as the related underlying RSUs.
Moelis & Company’s General Counsel and Secretary, Osamu Watanabe, reported awards of dividend-equivalent restricted stock units (RSUs) on 12/04/2025 in a Form 4 filing. These derivative awards carry a conversion or exercise price of $0, reflecting that they are stock-based incentives rather than options requiring a purchase price.
The RSUs were granted as Incentive RSUs tied to earlier unvested RSU awards made on February 19, 2021, February 17, 2022, February 16, 2023, February 15, 2024, and February 13, 2025. Each dividend-equivalent Incentive RSU will vest at the same time as the related underlying unvested Incentive RSUs. Upon settlement, each RSU gives the right to receive either one share of Moelis & Company Class A common stock or an equivalent cash amount, at the company’s option.
Moelis & Company director Kenneth Shropshire reported new stock-based awards in a Form 4 dated December 4, 2025. The filing shows automatic grants of restricted stock units (RSUs) issued as dividend equivalents on his existing Moelis equity awards.
He received 20.81 2024 Annual RSUs, 17.37 2025 Annual RSUs, and 1.54 2025 Elective RSUs, each representing the right to receive one share of Class A common stock. These dividend-equivalent RSUs will vest at the same time as the underlying RSUs to which they relate. Following these grants, he directly beneficially owns 2,148.72 2024 Annual RSUs, 1,793.09 2025 Annual RSUs, and 158.84 2025 Elective RSUs.
Moelis & Company director reports dividend-equivalent RSUs
A Moelis & Company director filed a Form 4 reporting automatic grants of dividend-equivalent restricted stock units (RSUs) tied to earlier equity awards. On 12/04/2025, the director received 2,051.34 2024 Annual RSUs, 1,711.63 2025 Annual RSUs, and 1,406.17 2025 Elective RSUs. Each RSU represents the right to receive one share of Moelis Class A common stock.
The 2024 Annual RSUs were issued as dividend equivalents on Annual RSUs granted on July 1, 2024, while the 2025 Annual and 2025 Elective RSUs were issued as dividend equivalents on awards granted on July 1, 2025. All of these dividend-equivalent RSUs will vest on the same schedule as their respective underlying RSU awards.
Moelis & Company director Thorold Barker reported an acquisition of restricted stock units tied to the firm’s Class A common stock. The filing shows a grant of 2025 Annual Restricted Stock Units, which were issued as dividend equivalents on Barker’s existing Annual RSUs that were originally granted on July 14, 2025. Each RSU represents the right to receive one share of Class A common stock.
The dividend equivalent RSUs will vest at the same time and on the same schedule as the underlying Annual RSUs. Following this transaction, Barker is reported to beneficially own 1,630.18 shares of Moelis & Company Class A common stock directly, indicating his ongoing equity alignment with the company as a board member.
Moelis & Company executive Eric Cantor, a director and Vice Chairman/Managing Director, reported routine equity compensation activity in Class A common stock. On 12/05/2025, 668.41 shares were acquired following the exercise of restricted stock units and then an equal number of shares was disposed of at $66.45 per share, leaving 218,805 Class A shares held directly.
Related derivative entries show multiple grants of incentive and long-term incentive restricted stock units on 12/04/2025, all with a conversion price of $0, representing stock-based awards. The explanations state these RSUs were largely issued as dividend equivalents on previously granted unvested RSUs and will vest in line with those underlying awards. Certain RSUs and shares were settled or used specifically to satisfy tax obligations under the company’s retirement eligibility and tax policies.
Moelis & Company reported director equity awards tied to prior grants. Director Louise Mirrer filed a Form 4 for Restricted Stock Units (RSUs) in Moelis & Co Class A Common Stock as of 12/04/2025.
The filing shows several lines of 2024 and 2025 Annual RSUs that were acquired as dividend equivalents on her existing Annual RSU awards from September 2024, May 2025, and July 2025. Each RSU represents the right to receive one share of Class A Common Stock, and the dividend-equivalent RSUs will vest on the same schedule as the underlying Annual RSUs.
The form is filed for one reporting person, in her capacity as a director, and is signed by an attorney-in-fact on her behalf.
Moelis & Company reported an insider equity transaction for Principal Accounting Officer Nick Riehl. On 12/04/2025, Riehl received additional restricted stock units (RSUs) linked to the company’s Class A common stock, including 9.58, 2.41, and 3.21 RSUs tied to Class A shares at an exercise price of $0.
Each RSU represents the right to receive either a share of Class A common stock or cash equal to its fair market value upon settlement. The new RSUs were issued as dividend equivalents on unvested incentive and long-term incentive RSUs that were originally granted on February 15, 2024 and February 13, 2025. These dividend equivalent RSUs will vest at the same time as the related unvested underlying RSUs.
Moelis & Company (MC) insider transaction: Executive Chairman and Director Kenneth Moelis reported an automatic conversion on 10/30/2025, resulting in the acquisition of 73 shares of Class A common stock (code M).
Following this transaction, he beneficially owns 209,310 shares of Class A common stock. The filing also shows 4,191,326 derivative securities (Class B common stock) beneficially owned after the reported transaction. Footnotes indicate the conversion occurred pursuant to the company’s charter when certain Group Units were exchanged by selling stockholders.
FAQ
What is the current stock price of Moelis & Co (MC)?
What is the market cap of Moelis & Co (MC)?
